Results 261 to 270 of about 1,781,803 (291)
Some of the next articles are maybe not open access.
Antifungal therapy in invasive fungal infections
Current Opinion in Pharmacology, 2010Early treatment of invasive fungal infections (IFIs) is essential for optimal clinical outcomes. Standard antifungal drugs (polyenes, azoles and echinocandins) are not predictably effective against emerging yeasts and filamentous fungi and may cause undesirable side effects. Species identification can guide antifungal selection for invasive candidiasis,
Chen, Sharon C-A. +2 more
openaire +5 more sources
Archives of Internal Medicine, 1983
• Serologic tests are useful in providing a presumptive diagnosis of invasive fungal infection, allowing early institution of specific therapy. The judicious use of these serologic tests for circulating antibodies or antigens also may aid in analyzing response to treatment and in assessing prognosis.
openaire +1 more source
• Serologic tests are useful in providing a presumptive diagnosis of invasive fungal infection, allowing early institution of specific therapy. The judicious use of these serologic tests for circulating antibodies or antigens also may aid in analyzing response to treatment and in assessing prognosis.
openaire +1 more source
Caspofungin in the treatment of invasive fungal infections
Intensive and Critical Care Nursing, 2006Caspofungin is a member of a new class of antifungals called Echinocandins and is the first to have marketing authorisation in the United Kingdom. This article reviews the clinical efficacy, side effect profile, dosing and administration schedule of caspofungin.
Simon, Keady, Meera, Thacker
openaire +2 more sources
Invasive fungal infections in the pediatric population
Expert Review of Anti-infective Therapy, 2011Expert Rev. Anti Infect. Ther. 9(3), 275-278 (2011) Invasive fungal infections (IFIs) are increasing in incidence and constitute an important cause of morbidity and mortality in immunocompromised pediatric patient populations, including, but not limited to, preterm neonates, children and adolescents with hematologic malignancies, and those undergoing ...
Thomas, Lehrnbecher, Andreas H, Groll
openaire +2 more sources
Invasive Fungal Infections in the Era of Biologics
Clinics in Chest Medicine, 2009With the advent and widespread use of immunomodulating biologic agents, emerging invasive fungal infections are reported increasingly. To date there is no reliable method to screen patients before starting anti-tumor necrosis factor (TNF) therapy to predict their risk for acquiring fungal infections, partly because most of these infections are de novo ...
Tamra M, Arnold +2 more
openaire +2 more sources
Voriconazole in the treatment of invasive fungal infections
Intensive and Critical Care Nursing, 2005Fungal infections in immunocompromised patients in the Intensive Care Unit (ICU) are a major cause of mortality and morbidity and can lead to extended stays on the ICU. New antifungal drugs have been developed to increase treatment options to improve the clinical outcome.
Simon, Keady, Meera, Thacker
openaire +2 more sources
Invasive Fungal Infections in Children
Pediatric Infectious Disease Journal, 2009Hans Jürgen, Dornbusch +4 more
openaire +2 more sources
Invasive Fungal Infections of the Orbit
International Ophthalmology Clinics, 2007James, Kirszrot, Peter A D, Rubin
openaire +2 more sources
Serology anno 2021—fungal infections: from invasive to chronic
Clinical Microbiology and Infection, 2021Cornelia Lass-Florl, Eldina Samardzic
exaly
Invasive Fungal Infections Complicating COVID-19: A Narrative Review
Journal of Fungi (Basel, Switzerland), 2021Spinello Antinori, Giacomo Casalini
exaly